Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2386]

Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs called PARP inhibitors

Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs called PARP inhibitors

EAU 13: Epigenetic changes play a key role in development of chemo resistance in BCa

EAU 13: Epigenetic changes play a key role in development of chemo resistance in BCa

EAU 13: Japanese P2 study shows potential of combined vaccine and steroid drug in castration resistant PCa

EAU 13: Japanese P2 study shows potential of combined vaccine and steroid drug in castration resistant PCa

EAU 13: Stem cells transplantation technique has high potential as a novel therapeutic strategy for ED

EAU 13: Stem cells transplantation technique has high potential as a novel therapeutic strategy for ED

A patient charter for CINV management

A patient charter for CINV management

Therapies for ALL and AML targeting MER receptor hold promise of more effect with less side-effect

Therapies for ALL and AML targeting MER receptor hold promise of more effect with less side-effect

NICE consults on preliminary recommendations for a new treatment for enlarged spleen in adults with myelofibrosis

NICE consults on preliminary recommendations for a new treatment for enlarged spleen in adults with myelofibrosis

Duration of hormone therapy for high-risk prostate cancer can be shortened without compromising treatment efficacy

Duration of hormone therapy for high-risk prostate cancer can be shortened without compromising treatment efficacy

Breast cancer gene provides vital clue to bowel cancer drug resistance

Breast cancer gene provides vital clue to bowel cancer drug resistance

Risk of leukaemia after cancer chemotherapy persists

Risk of leukaemia after cancer chemotherapy persists

More from ecancer